Press release - 30/06/2009 The genome as glue Many engineers who need to work with structured materials with small pores most likely dream of a glue that not only holds the tiny particles together, but also automatically brings them into contact at the correct distance from each other. Scientists under the leadership of Prof. Clemens Richert and Prof. Stefan Bräse at the Karlsruhe Institute of Technology (KIT) have now developed a “bioglue” using a process that is summarised in the journal…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/the-genome-as-glue
Press release - 11/08/2009 Merger of the University of Karlsruhe and the Karlsruhe Research Centre Federal Minister of Education and Research, Prof. Dr. Annette Schavan, and the Baden-Württemberg Minister of Science, Research and the Arts, Prof. Dr. Peter Frankenberg, signed the administrative agreement on the merger of the Karlsruhe Research Centre and the University of Karlsruhe on 30 July 2009.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/merger-of-the-university-of-karlsruhe-and-the-karlsruhe-research-centre
Press release - 14/12/2011 Towards a Therapy to Healing Stroke The thalamus is the central translator in the brain: Specialized nerve cells (neurons) receive information from the sensory organs, process it, and transmit it deep into the brain. Researchers from the Institute of Toxicology and Genetics (ITG) of KIT have now identified the genetic factors Lhx2 and Lhx9 responsible for the development of these neurons. Their results contribute to understanding the development of the thalamus. In the long term,…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/towards-a-therapy-to-healing-stroke
Press release - 17/05/2010 Bioliq® pilot plant at KIT close to completion The completion of the bioliq® pilot plant on the northern campus of the Karlsruhe Institute of Technology (KIT) is now a certainty. Following the commitment by the German and Baden-Württemberg governments to provide 11 million euros in financing, the KIT has now also signed contracts with companies that will work with KIT in the implementation of the two final processing stages. These two stages involve the production of second-generation…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/bioliq-pilot-plant-at-kit-close-to-completion
Press release - 12/10/2009 KIT takes off – University of Karlsruhe and the Karlsruhe Research Centre merged into one single entity on 1st October 2009 Almost three years after winning the German government’s Excellence Initiative, the idea has now become reality: On 1st October 2009, the University of Karlsruhe and the Karlsruhe Research Centre (Forschungszentrum Karlsruhe) merged to become a single legal entity known as the KIT, according to the Act on the Establishment of the Karlsruhe Institute of Technology. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/kit-takes-off-university-of-karlsruhe-and-the-karlsruhe-research-centre-merged-into-one-single-entit
Press release - 10/12/2009 Hydrogen from microalgae Hydrogen (H2) produced from water has great potential to be an environmentally friendly energy carrier of the future. However, the future application of hydrogen and other CO2-neutral sustainable fuels also requires the development of production methods that can contribute to the energy supply of tomorrow. Some unicellular green algae and cyanobacteria use light to break up water into hydrogen and oxygen. In cooperation with eight partners, KIT…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/hydrogen-from-microalgae
Press release - 27/07/2018 KIT Takes the Next Step: Federal and State Ministries Determined to Push KIT’s Further Development To further support and develop the scientific capacity of Karlsruhe Institute of Technology (KIT), the federal and state governments are determined to take the courageous merger of 2009 to the next level. During their joint visit of KIT today, Federal Minister of Education and Research Anja Karliczek and the Baden-Württemberg Minister for Science, Research and the Arts Theresia Bauer agreed on the next steps. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/kit-takes-the-next-step-federal-and-state-ministries-determined-to-push-kits-further-development
Press release - 10/06/2009 New Research Programme BioInterfaces launched The research center Karlsruhe of the Helmholtz Association and the University of Karlsruhe are represented in the Karlsruhe Institute of Technology. The programme BioInterfaces brings together a team of scientist of several fields to build up a link between science and teachings. 67 research teams develop with an annual budget of approximately 20 Million Euro innovative tools and technologies for precisely controlling the behaviour of cells.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/new-research-programme-biointerfaces-launched
Press release - 22/06/2009 New important triggers for the migration of cancer cells Embryonic cells and metastasising cancer cells are able to migrate and intrude into other tissues. Investigations of frog embryos have now provided scientists at the Karlsruhe Institute of Technology with the information that a well-known protein, cadherin-11, triggers cell migration. This glycoprotein is also responsible for the defective behaviour of cells that results in prostate cancer and arthritis. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/new-important-triggers-for-the-migration-of-cancer-cells
Press release - 26/01/2010 KIT is the most successful German institution in acquiring European research funds Under the 6th Research Framework Programme of the European Union, the Karlsruhe Institute of Technology acquired more than 80 million euros in research funds and was involved in 209 research projects. These figures show that it outperforms all other individual institutions in Germany, including universities, research centres and industrial companies. KIT has also had a successful start to the 7th Framework Programme.https:////www.gesundheitsindustrie-bw.de/en/article/press-release/kit-is-the-most-successful-german-institution-in-acquiring-european-research-funds
Press release - 22/05/2012 Microscope looks into cells of living fish Microscopes provide valuable insights in the structure and dynamics of cells, in particular when the latter remain in their natural environment. However, this is very difficult especially for higher organisms. Researchers of Karlsruhe Institute of Technology (KIT), the Max Planck Institute for Polymer Research, Mainz, and the American National Institutes of Health (NIH) have now developed a new method to visualize cell structures of an eighth of…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/microscope-looks-into-cells-of-living-fish
Article - 01/07/2009 KIT - Competence in bioprocess engineering The purification of microbially produced substances such as proteins and polysaccharides and their separation from or release from within the cell are complex tasks in the field of biotechnology. The Bioprocess Engineering department of the Institute of Process Engineering in the Life Sciences TH deals with the development of integrated bioprocesses and is also involved in the separation of biopolymers.https:////www.gesundheitsindustrie-bw.de/en/article/news/kit-competence-in-bioprocess-engineering
Article - 11/04/2011 movisens GmbH – innovative systems for measuring psychophysiological parameters In an effort to reduce the number of visits to GPs or clinics whilst enabling doctors to closely monitor their patients ECG breathing or physical activity Karlsruhe-based movisens GmbH offers mobile systems for measuring physiological parameters. The companys clients include research institutions hospitals employers and the police and fire brigade.https:////www.gesundheitsindustrie-bw.de/en/article/news/movisens-gmbh-innovative-systems-for-measuring-psychophysiological-parameters
Article - 04/01/2008 Karlsruhe Institute of Technology (KIT) established The University of Karlsruhe and the Karlsruhe Research Centre have set up the Karlsruhe Institute of Technology KIT. The signing of the cooperation agreement is the first milestone on the way to a total merger which both partners hope will eventually become reality. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/karlsruhe-institute-of-technology-kit-established
Press release - 26/02/2011 Science & Management “Science & Management“ is the name of an innovative doctoral programme offered by the Karlsruhe Institute of Technology in association with the international Collège des Ingénieurs. This is a world-first in Germany that enables students to combine a doctoral thesis in the sciences with an MBA - Master of Business Administration - degree. Study periods and project work in European countries are part of the programme, which will be open for…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/science-management
Article - 16/04/2012 DNA recombination for targeted plant breeding Did evolution invent games of chance? During the development of sperm and egg cells, maternal and paternal genes are mixed at random, thus giving rise to new combinations of traits. What are the molecular mechanisms of this process known as DNA recombination? How can it be used to breed plants with higher yields? Prof. Dr. Holger Puchta and his team at the Karlsruhe Institute of Technology (KIT) are investigating the processes associated with the…https:////www.gesundheitsindustrie-bw.de/en/article/news/dna-recombination-for-targeted-plant-breeding
Press release - 09/07/2010 Protein with a double light switch Researchers led by Professor Gerd Ulrich Nienhaus from the KIT have developed a new fluorescent marker protein. The photoactivatable fluorescent protein mIrisFP enables reversible photoswitching between fluorescent and nonfluorescent state as well as conversion from a green-emitting to a red-emitting form. The protein is suitable for carrying out dynamic investigations on cells and organisms and opens up new opportunities in cell biological and…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/protein-with-a-double-light-switch
Press release - 14/02/2009 Small but effective first aider In Germany alone around 100000 people per year suffer from sudden cardiac arrest which frequently occurs as a result of cardiac infarction serious injuries following an accident or electric shock. The job of first aiders is often impeded by the fact that it is difficult to correctly diagnose the disorder. A new first-aid sensor is now able to quickly provide information about the cardiovascular state of the injured personhttps:////www.gesundheitsindustrie-bw.de/en/article/press-release/small-but-effective-first-aider
Article - 19/03/2012 Protein aggregation: when proximity becomes dangerous The aggregation of proteins in the human body might have severe medical consequences, as is the case with Alzheimer’s disease, for example. A less known fact is that the biopharmaceutical industry is also faced with the biological phenomenon of protein aggregation and is working on preventive measures. https:////www.gesundheitsindustrie-bw.de/en/article/news/protein-aggregation-when-proximity-becomes-dangerous
Press release - 28/01/2009 Research on fish Following the expansion of the fish facilities at the Institute of Toxicology and Genetics (ITG) in Karlsruhe, Germany, the researchers from Karlsruhe now have more than 8,000 fish tanks at their disposal for research purposes. The ITG researchers’ principal area of focus is the systematic analysis of key molecules in development and regeneration processes, which makes an important contribution to the BioInterfaces research programme of the…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/research-on-fish
Article - 23/05/2011 KIT researchers attempt to grow cardiomyocytes in Petri dishes Regenerative medicine specialists are aiming to be able to grow complete organs from stem cells some time in the future. However although the microscopically small cells are able to do many things they are not able to grow organs on their own. Dr. Alexandra Rolletschek and her team at the Karlsruhe Institute of Technology KIT are investigating how stem cells can be grown into heart muscle cells cardiomyocytes in Petri dishes. https:////www.gesundheitsindustrie-bw.de/en/article/news/kit-researchers-attempt-to-grow-cardiomyocytes-in-petri-dishes
Guest article - 30/04/2012 First-hand experience: what it is like to do an internship at Boehringer Ingelheim in Shanghai Diana Schwarz is studying bioengineering at the Karlsruhe Institute of Technology (KIT) and also did a practical internship at Boehringer Ingelheim in Shanghai. Here she reports on her stay abroad.https:////www.gesundheitsindustrie-bw.de/en/article/news/first-hand-experience-what-it-is-like-to-do-an-internship-at-boehringer-ingelheim-in-shanghai
Article - 23/01/2012 Karen Lienkamp: intelligent surface materials fight off microbes Resistant germs are tough and will settle anywhere. They grow on all types of surface which is a major cause for concern for medical doctors and industrial researchers alike. The chemist Dr. Karen Lienkamp Junior Fellow at the Freiburg Institute for Advanced Studies FRIAS and head of a group of junior researchers at the University of Freiburg develops surface materials for biomedical applications and industrial production facilities. https:////www.gesundheitsindustrie-bw.de/en/article/news/karen-lienkamp-intelligent-surface-materials-fight-off-microbes
Press release - 18/12/2010 Gold for a construction kit full of viruses With a new strategy for the treatment of tumours, the team at the Freiburg Centre for Biological Signalling Studies (BIOSS) excellence cluster once again secured a top place in the international iGEM competition held by the Massachusetts Institute of Technology (MIT) in Cambridge, USA. https:////www.gesundheitsindustrie-bw.de/en/article/press-release/gold-for-a-construction-kit-full-of-viruses
Press release - 15/07/2014 amcure Receives EUR 5 Million Funding for the Development of New Tumour Therapeutic Agents amcure GmbH, a spin-off from the Karlsruhe Institute of Technology (KIT), has closed a Series A financing deal amounting to a total of EUR 5 million. The funding comes from a consortium headed by LBBW Venture Capital, with participations from KfW, MBG Mittelständische Beteiligungsgesellschaft Baden-Wuerttemberg, S-Kap Beteiligungen Pforzheim, BioM AG as well as private investors. The company also receives subsidies from the German Ministry of…https:////www.gesundheitsindustrie-bw.de/en/article/press-release/amcure-receives-eur-5-million-funding-for-the-development-of-new-tumour-therapeutic-agents